Autoantibodies in primary Sjögren's syndrome: New insights into mechanisms of autoantibody diversification and disease pathogenesis

Autoimmunity

Volumn 34, Issue 2, 2001, Pages 123-132

  Gordon, Tom P ^a   Bolstad, A I ^a   Rischmueller, M ^a   Jonsson, R ^a   Waterman, S A ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Autoantibodies; Sj gren's syndrome

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ALLOANTIBODY; AUTOANTIBODY; AUTOANTIGEN; CARBACHOL; CHAPERONE; GRP78; HEAT SHOCK PROTEIN; LA ANTIBODY; MUSCARINIC AGENT; MUSCARINIC M3 RECEPTOR ANTAGONIST; RO ANTIBODY; RO52; UNCLASSIFIED DRUG;

ALLELE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; CROSS REACTION; DISEASE MARKER; HUMAN; IMMUNE RESPONSE; PARASYMPATHETIC NERVE; PATHOGENESIS; PROTEIN FUNCTION; REVIEW; SALIVARY GLAND DUCT; SJOEGREN SYNDROME;

EID: 0035712662     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916930109001960     Document Type: Review

References (75)

1. Sjögren's syndrome
2. Determinant spreading: Lessons from animal models and human disease
3. Preliminary criteria for the classification of Sjögren's syndrome: Results of a prospective concerted action supported by the European Community
4. Analysis of B-cell epitopes of the Ro/SS-A autoantigen
5. Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins
6. How does autoimmunity to La and Ro initiate and spread?
7. Epitope mimics and determinant spreading: Pathways to autoimmunity
8. Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self antigen La (SS-B) permits induction of systemic autoimmunity in normal mice
9. Immune tolerance to the nuclear antigen La and constitutive presentation of nuclear antigen by autoreactive B cells
10. A 52-kD protein is a novel component of the SSA-Ro antigen particle
11. Purification of antigenically intact Ro ribonucleoproteins: Biochemical and immunological evidence that the 52-kD protein is not a Ro protein
12. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
13. Non-precipitating anti-La(SS-B) autoantibodies in primary Sjögren's syndrome
14. Recombinant 52kDa Ro(SS-A) ELISA detects autoantibodies in Sjögren's syndrome that go undetected by conventional serologic assays
15. Molecular chaperones are targets of autoimmunity in Ro(SS-A) immune mice
16. Autoimmunity heats up - A role for endogenous heat shock proteins?
17. A mechanism for the specific immunogenicity of heat shock protein - Chaperoned peptides
18. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways
19. Heat shock proteins refine danger theory
20. HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS)
21. Lupus, DNase and defective disposal of cellular debris
22. TCR in Fas sensitive T cells from labial salivary glands of patients with Sjögren's syndrome
23. Bcl-2 family expression in salivary glands from patients with primary Sjögren's syndrome: Involvement of Bax in salivary gland destruction
24. Salivary gland apoptosis in primary Sjögren's syndrome: A controlled study
25. Fas-induced apoptosis is a rare event in Sjögren's syndrome
26. The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome
27. Sjögren's syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression
28. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome
29. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody
30. HLA markers and clinical characteristics in primary Sjögren's syndrome
31. Primary Sjögren's syndrome: Role of the HLA-DRB1*0301-*1501 heterozygotes
32. Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome
33. Specific amino acid residues in the second hypervariable region of HLA- DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses
34. Distinct immunologic features of Finnish Sjögren's syndrome patients with HLA alleles DRB1*0301, DQA1*0501, and DQB1*0201. Alterations in circulating T cell receptor gamma/delta subsets
35. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome
36. Specific HLA-DQA and HLA-DRB1 alleles confer susceptibility to Sjögren's syndrome and autoantibody production
37. Association of anti-Ro/SS-A autoantibodies with glutamine in position 34 of DQA1 and leucine in position 26 of DQB1
38. Molecular analysis of HLA class II genes in primary Sjögren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients
39. Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjögren's syndrome
40. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome
41. Class II antigens and disease susceptibility
42. Association of DR3 with susceptibility to and severity of primary Sjögren's syndrome in a family study
43. Occurrence of antibody to salivary duct epithelium in Sjögren's disease. Rheumatoid arthritis and other arthritides - A clinical and laboratory study
44. Antibodies to salivary duct cells and other autoantibodies, in patients with Sjögren's syndrome and other idiopathic autoimmune diseases
45. Salivary duct autoantibody in Sjögren's syndrome: Correlation with focal sialadenitis in the labial mucosa
46. Antibodies to AB blood group antigens mimic anti-salivary duct autoantibodies in patients with limited sicca symptoms
47. The high-molecular weight human mucin is the primary salivary carrier of ABH, Le a and Le b blood group antigens
48. Autoantibodies in primary Sjögren's syndrome are directed against proteosomal subunits of the alpha and beta type
49. A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjögren's syndrome
50. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis
51. Antibodies to CD4 in primary Sjögren's syndrome
52. Identification of α-fodrin as a candidate autoantigen in primary Sjögren's syndrome
53. Anti-α-fodrin antibodies: Not specific nor sensitive for Sjogren's syndrome
54. Sjögren's syndrome
55. Evolving concepts of diagnosis, pathogenesis and therapy of Sjögren's syndrome
56. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis: Analysis of 618 patients with suspected Sjögren's syndrome
57. Progression of sialadenitis in Sjögren's syndrome
58. Sjögren's syndrome - Time for a new approach
59. An investigation of interactions between the immune system and stimulus secretion coupling in mouse submandibular acinar cells. A possible mechanism to account for reduced salivary flow rates associated with the onset of Sjögren's syndrome
60. null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome
61. Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice
62. 3 muscarinic receptors in primary Sjogren's syndrome
63. 3 muscarinic acetylcholine receptors in patients with primary Sjogren's syndrome
64. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome
65. Sjögren's syndrome in patients with interstitial cystitis
66. Adie syndrome as the initial sign of primary Sjögren's syndrome
67. Autonomic neuropathy associated with sicca complex
68. Multisystem neuronal involvement and sicca complex: Broadening the spectrum of complications
69. Autonomic cardiovascular neuropathy in Sjögren's syndrome: A controlled study
70. Does autonomic nervous impairment have a role in pathophysiology of Sjögren's syndrome
71. An alternative perspective to the immune response in autoimmune exocrinopathy: Induction of functional quiescence rather than destructive autoaggression
72. Interstitial cystitis: A review of immunological aspects of the aetiology and pathogenesis, with a hypothesis
73. Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: Pathological implications
74. Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy
75. Patients with preeclampsia develop agonistic autoantibodies against angiotensin AT1 receptor